A study found regular use of strong anticholinergic drugs used for bladder conditions, Parkinson's disease and depression ...

Patients with diabetes undergoing hemodialysis who initiate GLP-1 agonists have an 18% lower risk for incident dementia than ...

Care for patients with dementia has changed radically since Jason Karlawish started working in the field in the late ’90s, he ...

A new international study published in Osteoporosis International and led by Monash's Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

Memory care operators are moving from simply providing “good caregiving” to creating a data-rich environment that allows for ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, ...

Two decades after the Women’s Health Initiative study, evolving research on menopause hormone therapy is shedding new light ...

Dr Kellyn Lee has highlighted sundowning, a lesser-known sign of dementia that often becomes more noticeable in the afternoon ...

The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...